Harkiran K Kooner1,2, Maksym S Sharma1,2, Marrissa J McIntosh1,2, Inderdeep Dhaliwal3, J Michael Nicholson3, and Grace Parraga1,2,3
1Department of Medical Biophysics, Western University, London, ON, Canada, 2Robarts Research Institute, London, ON, Canada, 3Division of Respirology, Department of Medicine, Western University, London, ON, Canada
Synopsis
Keywords: Hyperpolarized MR (Gas), Lung
Post-acute COVID-19 syndrome (PACS) is an
umbrella term for symptoms and poor
quality-of-life, four weeks+ after acute COVID-19 infection, reported in up to
30% of COVID-19 survivors. The longitudinal trajectory of PACS remains largely
unknown.
129Xe MRI ventilation defects did not help to explain
longitudinal quality-of-life outcomes in PACS and thus, texture analysis was
used to evaluate potential ventilation features that could explain
quality-of-life. We identified the
129Xe MRI ventilation texture features
that predicted clinically relevant quality-of-life improvements 15-months
post-infection, outperforming clinical models. These findings also suggest that
ventilation texture features capture underlying pathophysiology not reflected
by ventilation-defect-percent.
INTRODUCTION
Post-acute
COVID-19 syndrome (PACS) is defined by persistent symptoms and poor
quality-of-life four-weeks+ post-acute COVID-19 in ~6-30% of patients.1,2 The St.
George’s Respiratory Questionnaire (SGRQ) score provides a measure of
quality-of-life that accounts for symptoms, activity limitation, and impact,3 and was
shown to be highly abnormal in patients with PACS.4 The
SGRQ-score allows for the longitudinal monitoring of post-COVID symptoms on
patient quality-of-life.
Although the pathologies
driving the pulmonary sequelae of COVID-19 remain poorly understood, previous
work has postulated the presence of an airways disease phenotype in PACS2,5 or a pulmonary vascular
phenotype defined by abnormal gas-exchange.6,7 Computed
tomography (CT) imaging has provided the primary imaging approach for diagnosis
and monitoring of COVID-19. Although the presence of air-trapping is used as an
indirect measure of small airways disease, the small airways are not easily
identified using chest CT.
Importantly, hyperpolarized
129Xe MRI provides a direct way to quantify inhaled gas distribution
abnormalities,8 including ventilation heterogeneity that stems from airway
luminal inflammation,9 airway obliteration,10 and occlusion.11 The binary
classification of ventilation defects defined as ventilation-defect-percent
(VDP) does not explain changes in PACS quality-of-life and so, we explored the
role of 129Xe MRI texture features, which can be used to evaluate
ventilation heterogeneity by extracting signal intensity differences in the
ventilated regions. Previous work reported significantly different 129Xe
MRI texture features between PACS participants and healthy controls.12 Thus, 129Xe
MRI texture features may provide additional information, beyond ventilation
defects, associated with the persistent sequelae in PACS. The objective of this
study was to utilize machine-learning in combination with ventilation texture
feature analysis to predict clinically relevant improvements in quality-of-life
using 129Xe MRI. METHODS
We
evaluated 41 participants with persistent respiratory symptoms, who completed a
baseline visit 3-months post-infection and a 12-month follow-up. All
participants provided written informed consent to an approved protocol that
included 129Xe MRI, pulmonary function testing, and quality-of-life
questionnaires.4 SGRQ was
self-administered under supervision.3
Anatomical 1H
and hyperpolarized 129Xe MRI were acquired using a 3T Discovery
MR750 (General Electric Health Care, WI, USA) with broadband capability as
previously described.13,14 Anatomical 1H images were acquired
using a fast-spoiled gradient-recalled echo (FGRE) sequence (total acquisition
time, 8 seconds; TR msec/TE msec, 4.7/1.2; flip angle, 30°; field of view,
40×40 cm2; bandwidth, 24.4 kHz; 128×80 matrix, zero padded to
128×128; partial echo percentage, 62.5%; 15-17 slices; slice thickness, 15 mm;
no gap). Static ventilation images were acquired using a
three-dimensional FGRE sequence (total acquisition time, 14 s; TR msec/TE msec, 6.7/1.5; variable flip angle;
field of view, 40×40 cm2; bandwidth, 15.63 kHz; 128×128 matrix, zero
padded to 128×128; 14 slices; slice thickness, 15 mm; no gap). Participants
were instructed to inhale and hold 1.0 L of gas (100% N2 for anatomical
scan and 400 mL hyperpolarized 129Xe mixed with 600 mL 4He
for hyperpolarized scan) to ensure volume matched images.
Participants were
dichotomized by whether they experienced a change greater than the
minimal-clinically-important-difference (MCID) in SGRQ-score (≥4 points)15 15-months post-infection. Texture
features were extracted from the 3-dimensional application of
gray-level run-length, gap-length, zone-size, dependence, gray-tone
difference, and co-occurrence-matrices via PyRadiomics platform.16 Feature selection was performed using Boruta analysis
via a random forests classifier to identify MRI features that contributed to
the machine-learning model’s accuracy. Classification Learner application
(MATLAB R2020a) was used to test single and ensemble models. Model performance
was evaluated using area under the receiver-operator-curve (AUC), as well as accuracy,
sensitivity, and specificity metrics.RESULTS
Table 1 provides demographic and imaging
characteristics for PACS participants, where 68% experienced a change >MCID
in SGRQ-score. Figure 1 shows 129Xe MRI for representative
participants in each group, where ventilation is qualitatively similar. Table 2
provides a summary of the best model performances for predicting improvement in
SGRQ-score≥4 points, where a weighted K-nearest neighbours (KNN) model
exclusively trained on MRI texture features was the best performer (AUC=0.91)
and outperformed models trained on clinical measures (AUC=0.75). Figure 2 shows
that, of the features in the MRI-model, ΔSGRQ significantly related to original shape
maximum 3D diameter (ρ=.39, p=.02) and minor axis length (ρ=.47, p=.005).DISCUSSION
Using machine learning methods, we identified 129Xe
MRI texture features that predicted 1-year quality-of-life improvement in
participants with PACS. Models consisting of MRI texture features outperformed
clinical models, where the KNN MRI-model using a weighted-neighbours approach
outperformed complex ensemble models. In addition, the change in SGRQ correlated
with maximum 3D diameter
and minor axis length, which informed on the overall shape and size of the
ventilation patchiness and distribution. The texture features in the MRI-model
also informed on fine textures that contribute to ventilation heterogeneity which
may be intuitively understood as fine “patchiness”. Thus, MRI texture features provided information about ventilation beyond the
binary classification of ventilated versus non-ventilated regions quantified
using VDP. The evaluation of signal intensity differences and spatial pixel locations
exploited by texture features help predict longitudinal quality-of-life
improvements in PACS.CONCLUSION
129Xe MRI ventilation texture feature extraction, enabled
using machine-learning, provided a method to predict which PACS participants
would experience clinically relevant 1-year quality-of-life improvements. 129Xe MRI ventilation texture
analysis may reveal underlying small airway pathophysiology contributing to
quality-of-life in PACS.Acknowledgements
No acknowledgement found.References
1 Nalbandian,
A. et al. Nat Med (2021).
2 Global Burden of Disease Long COVID
Collaborators JAMA (2022).
3 Jones, P.W. et al. Am Rev Respir Dis (1992).
4 Kooner, H.K. & McIntosh M.J. et al. BMJ Open Respir Res (2022).
5 Cho, J.L. et al. Radiology (2022).
6 Matheson, A.M. et al. Radiology (2022).
7 Grist, J.T. et al. Radiology (2022).
8 Kirby, M. et al. Acad Radiol
(2012).
9 Svenningsen, S. et al. Am J Respir Crit Care
Med (2018).
10 Svenningsen, S. et al. Thorax (2014).
11 Svenningsen, S. et al. Chest (2019).
12 Kooner, H.K. et al. ISMRM (2021).
13 Parraga, G. et al. Invest Radiol
(2007).
14 Svenningsen, S. et al. J Magn Reson Imaging
(2013).
15 Jones, P.W. COPD (2005).
16 Van Griethuysen, J.J. et al. Cancer Res (2017).